Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Changing the history of anaphylaxis mortality statistics through the World Health Organization's International Classification of Diseases-11.

Tanno LK, Chalmers R, Bierrenbach AL, Simons FER, Martin B, Molinari N, Annesi-Maesano I, Worm M, Cardona V, Papadopoulos NG, Sanchez-Borges M, Rosenwasser LJ, Ansontegui I, Ebisawa M, Sisul JC, Jares E, Gomez M, Agache I, Hellings P, Muraro A, Thien F, Pawankar R, Sublett JL, Casale T, Demoly P; Joint Allergy Academies.

J Allergy Clin Immunol. 2019 Sep;144(3):627-633. doi: 10.1016/j.jaci.2019.05.013. Epub 2019 Jun 20. Review.

PMID:
31229269
2.

Venom shortages: What's an allergist to do? Part 1, the issues.

Meadows JA, Golden DBK, Tracy J, Reyes EG, Sublett J.

Ann Allergy Asthma Immunol. 2019 Jul;123(1):9-10. doi: 10.1016/j.anai.2019.03.006. Epub 2019 Mar 13. No abstract available.

PMID:
30878627
3.

Venom shortages: What's an allergist to do? part two: potential solutions.

Meadows JA, Golden DBK, Tracy J, Reyes EG, Sublett J.

Ann Allergy Asthma Immunol. 2019 Aug;123(2):131-132. doi: 10.1016/j.anai.2019.03.001. Epub 2019 Mar 13. No abstract available.

PMID:
30878626
4.

The importance of allergic disease in public health: an iCAALL statement.

Sánchez-Borges M, Martin BL, Muraro AM, Wood RA, Agache IO, Ansotegui IJ, Casale TB, Fleisher TA, Hellings PW, Papadopoulos NG, Peden DB, Sublett JL, Tilles SA, Rosenwasser L.

World Allergy Organ J. 2018 Apr 27;11(1):8. doi: 10.1186/s40413-018-0187-2. eCollection 2018. No abstract available.

5.

Current trends in food allergy-induced anaphylaxis management at school.

Greenhawt M, Wallace D, Sublett JW, Maughan E, Tanner A, Kelley KJ, Fineman S, White M, Cash G, Anderson C, Schoessler S, Gupta R, Pistiner M.

Ann Allergy Asthma Immunol. 2018 Aug;121(2):174-178. doi: 10.1016/j.anai.2018.04.015. Epub 2018 Apr 21. Review.

PMID:
29684568
6.

USP's revisions to sterile compounding standards and FDA guidance; impacts on mixing of allergen extracts.

Meadows JA, Imbeau S, Finerfrock B, Burke R, Sublett JL.

Ann Allergy Asthma Immunol. 2018 Jan;120(1):5-7. doi: 10.1016/j.anai.2017.11.007. No abstract available.

PMID:
29273129
7.

Multimodality 3D Superposition and Automated Whole Brain Tractography: Comprehensive Printing of the Functional Brain.

Konakondla S, Brimley CJ, Sublett JM, Stefanowicz E, Flora S, Mongelluzzo G, Schirmer CM.

Cureus. 2017 Sep 29;9(9):e1731. doi: 10.7759/cureus.1731.

8.

Effect of a mobile health, sensor-driven asthma management platform on asthma control.

Barrett MA, Humblet O, Marcus JE, Henderson K, Smith T, Eid N, Sublett JW, Renda A, Nesbitt L, Van Sickle D, Stempel D, Sublett JL.

Ann Allergy Asthma Immunol. 2017 Nov;119(5):415-421.e1. doi: 10.1016/j.anai.2017.08.002.

PMID:
29150069
9.

Case report: Left ventricular noncompaction cardiomyopathy and RASopathies.

Sublett JA, Prada CE, Jefferies JL.

Eur J Med Genet. 2017 Dec;60(12):680-684. doi: 10.1016/j.ejmg.2017.09.002. Epub 2017 Sep 12.

PMID:
28911804
10.

Left ventricular dysfunction in a patient with Angelman syndrome.

Powell AW, Taylor MD, Hopkin RJ, Sublett J, Jefferies JL.

Clin Dysmorphol. 2018 Jan;27(1):21-22. doi: 10.1097/MCD.0000000000000203. No abstract available.

PMID:
28877039
11.

Author's response.

Turbyville JC, Winslow AW, Sublett JW, Sublett JL, Pollard SJ.

Ann Allergy Asthma Immunol. 2017 Aug;119(2):195-196. doi: 10.1016/j.anai.2017.06.011. No abstract available.

PMID:
28801020
12.

A call to arms of specialty societies to review the WHO International Classification of Diseases, Eleventh Revision terms appropriate for the diseases they manage: The example of the Joint Allergy Academies.

Tanno LK, Casale T, Papadopoulos NG, Sanchez-Borges M, Thiens F, Pawankar R, Calderon MA, Gómez M, Sisul JC, Ansotegui IJ, Sublett J, Demoly P.

Allergy Asthma Proc. 2017 Jul 1;38(4):54-55. doi: 10.2500/aap.2017.38.4063. No abstract available.

PMID:
28668104
13.

Perspectives on the International Classification of Diseases, 11th Revision, developments in allergy clinical practice in the United States.

Tanno LK, Sublett JL, Meadows JA, Calderon M, Gross GN, Casale T, Demoly P; Joint Allergy Academies.

Ann Allergy Asthma Immunol. 2017 Feb;118(2):127-132. doi: 10.1016/j.anai.2016.11.003. Epub 2016 Dec 20. No abstract available.

PMID:
28010916
14.

Pediatric Primary Diffuse Leptomeningeal Primitive Neuroectodermal Tumor: A Case Report and Literature Review.

Sublett JM, Davenport C, Eisenbrock H, Dalal S, Jaffar Kazmi SA, Kershenovich A.

Pediatr Neurosurg. 2017;52(2):114-121. doi: 10.1159/000452807. Epub 2016 Dec 7. Review.

PMID:
27923222
15.

Comparison of systemic reactions in rush, cluster, and standard-build aeroallergen immunotherapy.

Winslow AW, Turbyville JC, Sublett JW, Sublett JL, Pollard SJ.

Ann Allergy Asthma Immunol. 2016 Nov;117(5):542-545. doi: 10.1016/j.anai.2016.09.005. Epub 2016 Oct 24.

PMID:
27788885
16.

Smoothing the transition from International Classification of Diseases, Tenth Revision, Clinical Modification to International Classification of Diseases, Eleventh Revision.

Tanno LK, Calderon M, Sublett JL, Casale T, Demoly P; Joint Allergy Academies.

J Allergy Clin Immunol Pract. 2016 Nov - Dec;4(6):1265-1267. doi: 10.1016/j.jaip.2016.06.024. Epub 2016 Aug 18. No abstract available.

PMID:
27546357
17.

Feasibility of Deploying Inhaler Sensors to Identify the Impacts of Environmental Triggers and Built Environment Factors on Asthma Short-Acting Bronchodilator Use.

Su JG, Barrett MA, Henderson K, Humblet O, Smith T, Sublett JW, Nesbitt L, Hogg C, Van Sickle D, Sublett JL.

Environ Health Perspect. 2017 Feb;125(2):254-261. doi: 10.1289/EHP266. Epub 2016 Jun 24.

18.

Surveying the new Allergic and hypersensitivity conditions chapter of the International Classification of Diseases (ICD)-11.

Tanno LK, Calderon MA, Papadopoulos NG, Sanchez-Borges M, Moon HB, Sisul JC, Jares EJ, Sublett JL, Casale T, Demoly P; Joint Allergy Academies.

Allergy. 2016 Sep;71(9):1235-40. doi: 10.1111/all.12945. No abstract available.

PMID:
27253871
19.

Revisiting Desensitization and Allergen Immunotherapy Concepts for the International Classification of Diseases (ICD)-11.

Tanno LK, Calderon MA, Papadopoulos NG, Sanchez-Borges M, Rosenwasser LJ, Bousquet J, Pawankar R, Sisul JC, Cepeda AM, Li J, Muraro A, Fineman S, Sublett JL, Katelaris CH, Chang YS, Moon HB, Casale T, Demoly P; Joint Allergy Academies.

J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):643-9. doi: 10.1016/j.jaip.2015.12.022. Epub 2016 Mar 8. Review.

PMID:
26969269
20.

International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics.

Jutel M, Agache I, Bonini S, Burks AW, Calderon M, Canonica W, Cox L, Demoly P, Frew AJ, O'Hehir R, Kleine-Tebbe J, Muraro A, Lack G, Larenas D, Levin M, Martin BL, Nelson H, Pawankar R, Pfaar O, van Ree R, Sampson H, Sublett JL, Sugita K, Du Toit G, Werfel T, Gerth van Wijk R, Zhang L, Akdis M, Akdis CA.

J Allergy Clin Immunol. 2016 Feb;137(2):358-68. doi: 10.1016/j.jaci.2015.12.1300. Review.

PMID:
26853128
21.

Addressing barriers to emergency anaphylaxis care: from emergency medical services to emergency department to outpatient follow-up.

Fineman SM, Bowman SH, Campbell RL, Dowling P, O'Rourke D, Russell WS, Sublett JW, Wallace D.

Ann Allergy Asthma Immunol. 2015 Oct;115(4):301-5. doi: 10.1016/j.anai.2015.07.008. Epub 2015 Sep 4.

PMID:
26256577
22.

A new method for air sampling with real-world results.

Sublett JL.

Ann Allergy Asthma Immunol. 2015 Mar;114(3):160-1. doi: 10.1016/j.anai.2015.01.005. No abstract available.

PMID:
25744896
23.

Simultaneous gene editing by injection of mRNAs encoding transcription activator-like effector nucleases into mouse zygotes.

Li C, Qi R, Singleterry R, Hyle J, Balch A, Li X, Sublett J, Berns H, Valentine M, Valentine V, Sherr CJ.

Mol Cell Biol. 2014 May;34(9):1649-58. doi: 10.1128/MCB.00023-14. Epub 2014 Feb 24.

24.

Environmental assessment and exposure control of dust mites: a practice parameter.

Portnoy J, Miller JD, Williams PB, Chew GL, Miller JD, Zaitoun F, Phipatanakul W, Kennedy K, Barnes C, Grimes C, Larenas-Linnemann D, Sublett J, Bernstein D, Blessing-Moore J, Khan D, Lang D, Nicklas R, Oppenheimer J, Randolph C, Schuller D, Spector S, Tilles SA, Wallace D; Joint Taskforce on Practice Parameters; Practice Parameter Workgroup.

Ann Allergy Asthma Immunol. 2013 Dec;111(6):465-507. doi: 10.1016/j.anai.2013.09.018. No abstract available.

25.

Environmental assessment and exposure reduction of cockroaches: a practice parameter.

Portnoy J, Chew GL, Phipatanakul W, Williams PB, Grimes C, Kennedy K, Matsui EC, Miller JD, Bernstein D, Blessing-Moore J, Cox L, Khan D, Lang D, Nicklas R, Oppenheimer J, Randolph C, Schuller D, Spector S, Tilles SA, Wallace D, Seltzer J, Sublett J; Joint Task Force on Practice Parameters.

J Allergy Clin Immunol. 2013 Oct;132(4):802-8.e1-25. doi: 10.1016/j.jaci.2013.04.061. Epub 2013 Aug 9. Review.

26.

Mouse allergen skin sensitization in asthmatic children of suburban, rural, and inner-city populations.

Kailasnath VP, Raj S, Sublett JL.

Allergy Asthma Proc. 2013 Mar-Apr;34(2):176-8. doi: 10.2500/aap.2013.34.3633.

PMID:
23484894
27.

Food allergy exposures among hospitalized pediatric patients.

Franxman TJ, Strothman KR, Sublett JL, Montgomery VL, Baptist AP.

Ann Allergy Asthma Immunol. 2013 Jan;110(1):56-7. doi: 10.1016/j.anai.2012.10.007. Epub 2012 Nov 8. No abstract available.

PMID:
23244661
28.

Neonatal abstinence syndrome: therapeutic interventions.

Sublett J.

MCN Am J Matern Child Nurs. 2013 Mar;38(2):102-7; quiz 107-9. doi: 10.1097/NMC.0b013e31826e978e. Review.

PMID:
23187048
29.

Environmental assessment and exposure reduction of rodents: a practice parameter.

Phipatanakul W, Matsui E, Portnoy J, Williams PB, Barnes C, Kennedy K, Bernstein D, Blessing-Moore J, Cox L, Khan D, Lang D, Nicklas R, Oppenheimer J, Randolph C, Schuller D, Spector S, Tilles SA, Wallace D, Sublett J, Bernstein J, Grimes C, Miller JD, Seltzer J; Joint Task Force on Practice Parameters.

Ann Allergy Asthma Immunol. 2012 Dec;109(6):375-87. doi: 10.1016/j.anai.2012.09.019. No abstract available.

30.

Environmental assessment and exposure control: a practice parameter--furry animals.

Portnoy J, Kennedy K, Sublett J, Phipatanakul W, Matsui E, Barnes C, Grimes C, Miller JD, Seltzer JM, Williams PB, Bernstein JA, Bernstein DI, Blessing-Moore J, Cox L, Khan DA, Lang DM, Nicklas RA, Oppenheimer J.

Ann Allergy Asthma Immunol. 2012 Apr;108(4):223.e1-15. doi: 10.1016/j.anai.2012.02.015. No abstract available. Erratum in: Ann Allergy Asthma Immunol. 2012 Sep;109(3):229.. multiple author names added.

31.

Characterization of patients with suspected seminal plasma hypersensitivity.

Sublett JW, Bernstein JA.

Allergy Asthma Proc. 2011 Nov-Dec;32(6):467-71. doi: 10.2500/aap.2011.32.3495.

PMID:
22221443
32.

Occupational rhinitis.

Sublett JW, Bernstein DI.

Immunol Allergy Clin North Am. 2011 Nov;31(4):787-96, vii. doi: 10.1016/j.iac.2011.07.007. Review.

PMID:
21978857
33.

Seminal plasma hypersensitivity reactions: an updated review.

Sublett JW, Bernstein JA.

Mt Sinai J Med. 2011 Sep-Oct;78(5):803-9. doi: 10.1002/msj.20283. Review.

PMID:
21913207
34.

Effectiveness of air filters and air cleaners in allergic respiratory diseases: a review of the recent literature.

Sublett JL.

Curr Allergy Asthma Rep. 2011 Oct;11(5):395-402. doi: 10.1007/s11882-011-0208-5. Review.

35.

Occupational rhinitis.

Sublett JW, Bernstein DI.

Curr Allergy Asthma Rep. 2010 Mar;10(2):99-104. doi: 10.1007/s11882-010-0094-2.

PMID:
20425501
36.

Air filters and air cleaners: rostrum by the American Academy of Allergy, Asthma & Immunology Indoor Allergen Committee.

Sublett JL, Seltzer J, Burkhead R, Williams PB, Wedner HJ, Phipatanakul W; American Academy of Allergy, Asthma & Immunology Indoor Allergen Committee.

J Allergy Clin Immunol. 2010 Jan;125(1):32-8. doi: 10.1016/j.jaci.2009.08.036. Epub 2009 Nov 11. Review.

37.

Calcium efflux is essential for bacterial survival in the eukaryotic host.

Rosch JW, Sublett J, Gao G, Wang YD, Tuomanen EI.

Mol Microbiol. 2008 Oct;70(2):435-44. doi: 10.1111/j.1365-2958.2008.06425.x. Epub 2008 Aug 29.

38.

Convergence of regulatory networks on the pilus locus of Streptococcus pneumoniae.

Rosch JW, Mann B, Thornton J, Sublett J, Tuomanen E.

Infect Immun. 2008 Jul;76(7):3187-96. doi: 10.1128/IAI.00054-08. Epub 2008 Apr 28.

39.

Assessment of molecular typing methods to determine invasiveness and to differentiate clones of Streptococcus pneumoniae.

Obert CA, Gao G, Sublett J, Tuomanen EI, Orihuela CJ.

Infect Genet Evol. 2007 Dec;7(6):708-16. Epub 2007 Jul 27.

40.

Identification of a Candidate Streptococcus pneumoniae core genome and regions of diversity correlated with invasive pneumococcal disease.

Obert C, Sublett J, Kaushal D, Hinojosa E, Barton T, Tuomanen EI, Orihuela CJ.

Infect Immun. 2006 Aug;74(8):4766-77.

41.

Multifunctional role of choline binding protein G in pneumococcal pathogenesis.

Mann B, Orihuela C, Antikainen J, Gao G, Sublett J, Korhonen TK, Tuomanen E.

Infect Immun. 2006 Feb;74(2):821-9.

42.

Vancomycin stress response in a sensitive and a tolerant strain of Streptococcus pneumoniae.

Haas W, Kaushal D, Sublett J, Obert C, Tuomanen EI.

J Bacteriol. 2005 Dec;187(23):8205-10.

43.

The environment and risk factors for atopy.

Sublett JL.

Curr Allergy Asthma Rep. 2005 Nov;5(6):445-50. Review.

PMID:
16216168
45.

Revising the role of the pneumococcal vex-vncRS locus in vancomycin tolerance.

Haas W, Sublett J, Kaushal D, Tuomanen EI.

J Bacteriol. 2004 Dec;186(24):8463-71.

46.

Microarray analysis of pneumococcal gene expression during invasive disease.

Orihuela CJ, Radin JN, Sublett JE, Gao G, Kaushal D, Tuomanen EI.

Infect Immun. 2004 Oct;72(10):5582-96.

47.

Tolerance to vancomycin in pneumococci: detection with a molecular marker and assessment of clinical impact.

Rodriguez CA, Atkinson R, Bitar W, Whitney CG, Edwards KM, Mitchell L, Li J, Sublett J, Li CS, Liu T, Chesney PJ, Tuomanen EI.

J Infect Dis. 2004 Oct 15;190(8):1481-7. Epub 2004 Sep 9.

PMID:
15378442
48.

Capsular expression in Streptococcus pneumoniae negatively affects spontaneous and antibiotic-induced lysis and contributes to antibiotic tolerance.

Fernebro J, Andersson I, Sublett J, Morfeldt E, Novak R, Tuomanen E, Normark S, Normark BH.

J Infect Dis. 2004 Jan 15;189(2):328-38. Epub 2003 Dec 30.

PMID:
14722899
49.

Pax3-FKHR knock-in mice show developmental aberrations but do not develop tumors.

Lagutina I, Conway SJ, Sublett J, Grosveld GC.

Mol Cell Biol. 2002 Oct;22(20):7204-16.

50.

Ethical decision making in assisted suicide.

Pratt MA, Melton-Freeman C, Calico PA, Yang C, McNeill M, Sublett J, Charasika M.

Ky Nurse. 1999 Jul-Sep;47(3):30-3. Review. No abstract available.

PMID:
11998026

Supplemental Content

Loading ...
Support Center